Related Experiment Video
Updated: Jul 25, 2026

05:47
Isolation of Murine Lymph Node Stromal Cells
Published on: August 19, 2014
31.3K
TRPC6 is ubiquitously present in lymphatic tissues: A study using samples from body donors
Felix Daum1, Fidelis Flockerzi2, Alessandro Bozzato3
1Institute of Anatomy and Cell Biology, Faculty of Medicine, Saarland University, D-66421 Homburg/Saar, Germany.
Medicine International
|August 20, 2024
Summary
Transient receptor potential canonical channel 6 (TRPC6) protein is present in human lymphoid tissues, including lymphocytes and vessels. This finding suggests TRPC6 may play roles in immune responses and leukocyte migration.
Area of Science:
- Immunology
- Cell Biology
- Physiology
Background:
- Transient receptor potential canonical channel 6 (TRPC6) is a cation channel implicated in various diseases.
- Previous studies on TRPC6 in lymphoid tissues were limited to mRNA or cell line analysis.
- The role of TRPC6 in human lymphoid organs remains largely unexplored.
Purpose of the Study:
- To investigate the presence and localization of TRPC6 protein in human lymphoid tissues using immunohistochemistry.
- To explore potential functions of TRPC6 in immune responses and leukocyte trafficking.
Main Methods:
- Human lymphatic tissues (lymph nodes, spleen, tonsil, gut-associated lymphoid tissues, thymus) were obtained from body donors.
- Immunohistochemical staining was performed using a validated anti-TRPC6 antibody.
- Hematoxylin and eosin (H&E) staining was used for morphological assessment.
Main Results:
- TRPC6 protein was detected in all analyzed human lymphoid tissues.
- Positive staining for TRPC6 was observed in lymphocytes, follicle-associated epithelium, and various blood and lymphatic vessels.
- Specific localization included high endothelial venules, suggesting a role in leukocyte migration.
Conclusions:
- TRPC6 is expressed throughout human lymphoid tissues, including immune cells and vasculature.
- TRPC6 may be involved in immune response regulation and leukocyte trafficking within lymphoid organs.
- Further research is warranted to explore TRPC6 as a potential therapeutic target in lymphoid-related conditions.

